MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on April 29, 2008; DOI: 10.1124/mol.108.044925


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.108.044925v1
74/2/371    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, Y.
Right arrow Articles by Neve, K. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, Y.
Right arrow Articles by Neve, K. A


Received for publication January 7, 2008.
Revised April 24, 2008.
Accepted for publication April 28, 2008.

Novel Interaction of the Dopamine D2 Receptor and the Ca2+-Binding Protein S100B: Role in D2 Receptor Function

Yong Liu 1, David C Buck 2, Kim A Neve 2*

1 Oregon Health & Science University 2 Oregon Health & Science University & Portland Veterans Affairs Medical Center

* Address correspondence to: E-mail: nevek{at}ohsu.edu

Abstract

S100B is a calcium binding protein with both extracellular and intracellular regulatory activities in the mammalian brain. We have identified a novel interaction between S100B and the dopamine D2 receptor. Our results also suggest that the binding of S100B to the dopamine D2 receptor enhances receptor signaling. This conclusion is based on the following observations: 1) S100B and the third cytoplasmic loop of the dopamine D2 receptor interact in a bacterial two-hybrid system and in a polyHis pull-down assay; 2) immunoprecipitation of the D2 receptor also precipitates FLAG-S100B from human embryonic kidney 293 cell homogenates and endogenous S100B from rat neostriatal homogenates; 3) S100B immunoreactivity was detected in cultured neostriatal neurons expressing the D2 receptor; 4) a putative S100B binding motif is located at residues 233-240 of the D2 receptor, towards the amino terminus of the third cytoplasmic loop. D3-IC3, which does not bind S100B, does not contain this motif; 5) co-expression of S100B in D2 receptor-expressing 293 cells selectively increased D2 receptor stimulation of extracellular signal-regulated kinases and inhibition of adenylate cyclase.


Key words: Dopamine, Adenylyl cyclases, MAP Kinase


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
G. D. Stanwood
Protein-Protein Interactions and Dopamine D2 Receptor Signaling: A Calcium Connection
Mol. Pharmacol., August 1, 2008; 74(2): 317 - 319.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics